Guojin Huang

1.1k total citations
44 papers, 899 citations indexed

About

Guojin Huang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Guojin Huang has authored 44 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Guojin Huang's work include RNA modifications and cancer (8 papers), Autophagy in Disease and Therapy (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Guojin Huang is often cited by papers focused on RNA modifications and cancer (8 papers), Autophagy in Disease and Therapy (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Guojin Huang collaborates with scholars based in China, United States and Austria. Guojin Huang's co-authors include Biwen Mo, Shmuel Muallem, Yi Gou, Junfei Jin, Feng Yang, Jinlong Li, Jianjun Yang, Weijia Liao, Hong Liang and Qingqing Wang and has published in prestigious journals such as Journal of Biological Chemistry, Coordination Chemistry Reviews and Journal of Cell Science.

In The Last Decade

Guojin Huang

41 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guojin Huang China	19	422	196	168	148	111	44	899
Anja Lüth Germany	14	675 1.6×	156 0.8×	81 0.5×	101 0.7×	89 0.8×	26	1.0k
Jiaqing Li China	21	471 1.1×	166 0.8×	94 0.6×	61 0.4×	55 0.5×	73	1.3k
Weiwei Mao China	20	572 1.4×	139 0.7×	84 0.5×	83 0.6×	56 0.5×	49	1.2k
Xing Wang China	20	466 1.1×	417 2.1×	168 1.0×	101 0.7×	128 1.2×	76	1.1k
Shuping Li China	20	778 1.8×	99 0.5×	348 2.1×	118 0.8×	67 0.6×	71	1.1k
Achilleas Mitrakas Greece	16	393 0.9×	188 1.0×	193 1.1×	106 0.7×	80 0.7×	37	839
Hanshuo Yang China	22	656 1.6×	261 1.3×	228 1.4×	92 0.6×	195 1.8×	57	1.2k
Qian Zhong China	16	420 1.0×	209 1.1×	154 0.9×	67 0.5×	52 0.5×	41	862
Nancy R. Leffler United States	10	539 1.3×	182 0.9×	166 1.0×	100 0.7×	91 0.8×	17	1.0k

Countries citing papers authored by Guojin Huang

Since Specialization

Citations

This map shows the geographic impact of Guojin Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guojin Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guojin Huang more than expected).

Fields of papers citing papers by Guojin Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guojin Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guojin Huang. The network helps show where Guojin Huang may publish in the future.

Co-authorship network of co-authors of Guojin Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Guojin Huang. A scholar is included among the top collaborators of Guojin Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guojin Huang. Guojin Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Guojin, Huanfeng Jiang, Qiang Zeng, & Wei Zeng. (2025). Cu(II)/Photoredox-Catalyzed Aminoacylation of Vinyl Bromides. Organic Letters. 27(13). 3482–3487.

Wang, Qingqing, Fengxia Chen, Guojun Jiang, et al.. (2025). RLIG1 promotes triple-negative breast cancer proliferation by activating mTORC1 signal pathway by interacting with ERK. Cellular Signalling. 134. 111969–111969.

Wang, Wenxin, et al.. (2024). Onset and prognostic features of anastomotic leakage in patients undergoing radical surgery after neoadjuvant chemoradiation for rectal cancer. World Journal of Gastrointestinal Surgery. 16(12). 3710–3719.

Hou, Lixia, Jianfeng Lan, Feng Yang, et al.. (2023). Mixed-ligand copper(II) hydrazone complexes: Synthesis, structure, and anti-lung cancer properties. Journal of Molecular Structure. 1279. 134986–134986. 16 indexed citations

Deng, Jungang, Chang Peng, Lixia Hou, et al.. (2022). Dithiocarbazate-copper complex loaded thermosensitive hydrogel for lung cancer therapy via tumor in situ sustained-release. Inorganic Chemistry Frontiers. 9(23). 6190–6201. 6 indexed citations

Mei, Wei, Bing Hong, & Guojin Huang. (2021). [Mechanism of high expression of high mobility group protein 1 in a rat model of knee osteoarthritis].. PubMed. 41(8). 1142–1149. 2 indexed citations

Gou, Yi, Meirong Chen, Shanhe Li, et al.. (2021). Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer. Journal of Medicinal Chemistry. 64(9). 5485–5499. 69 indexed citations

Han, Xiaodan, et al.. (2021). NICE‑3‑knockdown induces cell cycle arrest and autophagy in lung adenocarcinoma cells via the AKT/mTORC1 signaling pathway. Experimental and Therapeutic Medicine. 21(6). 625–625. 1 indexed citations

Huang, Guojin, et al.. (2021). MiR-23b targets GATA6 to down-regulate IGF-1 and promote the development of congenital heart disease. Acta cardiologica. Supplementum. 77(5). 375–384. 2 indexed citations

10.

Shi, Guocheng, Xinxin Chen, Xiaofeng Li, et al.. (2020). Impact of early Coronavirus Disease 2019 pandemic on pediatric cardiac surgery in China. Journal of Thoracic and Cardiovascular Surgery. 161(5). 1605–1614.e4. 9 indexed citations

11.

Wang, Qingqing, et al.. (2018). DEP domain containing 1 suppresses apoptosis via inhibition of A20 expression, which activates the nuclear factor κB signaling pathway in HepG2 cells. Oncology Letters. 16(1). 949–955. 18 indexed citations

12.

Huang, Guojin. (2017). [Importance of neonatal screening for congenital heart disease in China].. PubMed. 55(4). 241–243. 3 indexed citations

13.

Liu, Yujuan, et al.. (2017). Artesunate ameliorates lung fibrosis via inhibiting the Notch signaling pathway. Experimental and Therapeutic Medicine. 14(1). 561–566. 41 indexed citations

14.

Wang, Qingqing, et al.. (2017). Targeted interfering DEP domain containing 1 protein induces apoptosis in A549 lung adenocarcinoma cells through the NF-κB signaling pathway. OncoTargets and Therapy. Volume 10. 4443–4454. 21 indexed citations

15.

Gautam, Ajay Kumar, Changming Wang, Jinrong Zeng, et al.. (2015). Expression and clinical significance of SALL4 and LGR5 in patients with lung cancer. Oncology Letters. 10(6). 3629–3634. 14 indexed citations

16.

Yuan, Shengguang, Weijia Liao, Jianjun Yang, Guojin Huang, & Zhaoquan Huang. (2015). DEP Domain Containing 1 is a Novel Diagnostic Marker and Prognostic Predictor for Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention. 15(24). 10917–10922. 28 indexed citations

17.

Huang, Zhaoquan, Guojin Huang, Quanzhong Li, & Junfei Jin. (2014). p38 mitogen-activated protein kinase/activator protein-1 involved in serum deprivation-induced human alkaline ceramidase 2 upregulation. Biomedical Reports. 3(2). 225–229. 7 indexed citations

18.

Huang, Guojin, Jian Yao, Weizhong Zeng, et al.. (2005). ER stress disrupts Ca2+-signaling complexes and Ca2+ regulation in secretory and muscle cells from PERK-knockout mice. Journal of Cell Science. 119(1). 153–161. 56 indexed citations

19.

Guo, Ke‐Tai, et al.. (2003). [Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity].. PubMed. 19(6). 730–3. 1 indexed citations

20.

Huang, Guojin, Zhiqing Zhang, & Dong‐Yan Jin. (2002). Stimulation of IKK‐γ oligomerization by the human T‐cell leukemia virus oncoprotein Tax. FEBS Letters. 531(3). 494–498. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact